| Brand Name | ID CORE XT |
| Common Device Name | ANTIGEN GENOTYPING TEST |
| Manufacturer (Section D) |
| PROGENIKA BIOPHARMA, S.A |
| ibaizabal bidea, edificio 504 |
| parque tecnol?gico de bizkaia |
| derio, bizkaia 48160 |
| SP 48160 |
|
| Manufacturer (Section G) |
| PROGENIKA BIOPHARMA, S.A |
| ibaizabal bidea, edificio 504 |
| parque tecnol?gico de bizkaia |
| derio, bizkaia 48160 |
|
SP
48160
|
|
| Manufacturer Contact |
|
jokin
del amo
|
| ibaizabal bidea, edificio 504 |
| parque tecnol?gico de bizkaia |
| derio, bizkaia 48160
|
|
SP
48160
|
|
| MDR Report Key | 15613373 |
| Report Number | 3006413195-2022-00006 |
| Device Sequence Number | 7941295 |
| Product Code |
PEP
|
| UDI-Device Identifier | 08437013457019 |
| UDI-Public | (01)08437013457019(17)220622(10)0203000024 |
| Combination Product (Y/N) | N |
| Initial Reporter State | MN |
| Initial Reporter Country | US |
| PMA/510(K) Number | BP170154 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Serviced by Third Party (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Health Professional,Distributor |
| Initial Reporter Occupation |
Physician
|
| Type of Report
| Initial |
| Report Date (Section B) |
10/17/2022 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
No
|
| Is this a Product Problem Report? |
Yes
|
| Operator of Device |
Health Professional
|
| Device Expiration Date | 02/23/2023 |
| Device Model Number | v3 |
| Device Catalogue Number | 1021720000 |
| Device Lot Number | 0203000026 |
| Was Device Available for Evaluation? |
No
|
| Is the Reporter a Health Professional? |
Yes
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 09/16/2022 |
| Initial Report FDA Received Date | 10/17/2022 |
| Was Device Evaluated by Manufacturer? (Y/N) |
No
|
| Date Device Manufactured | 11/25/2021 |
| Is the Device Labeled for Single Use? (Y/N) |
No
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement | N/A |
| Patient Sequence Number | 1 |
| Patient Sex | Unknown |
|
|